Angelini Pharma
Angelini Pharma is a healthcare company that focuses on the development and commercialization of innovative products in mental health, pain and inflammation, and pediatrics. The organization aims to address significant medical needs by providing effective solutions and therapies that enhance patient care. With a commitment to improving health outcomes, Angelini Pharma leverages its expertise to deliver targeted treatments and support for various health conditions.
2 past transactions
Arvelle Therapeutics
Acquisition in 2021
Arvelle Therapeutics GmbH is a biopharmaceutical company headquartered in Zug, Switzerland, founded in 2019. The company is dedicated to developing and commercializing innovative treatments for patients suffering from central nervous system (CNS) disorders. Its primary focus is on cenobamate, an investigational antiepileptic drug aimed at providing effective solutions for patients experiencing focal seizures. Through its efforts, Arvelle Therapeutics seeks to enhance the quality of care available to individuals affected by debilitating neurological and neuromuscular diseases.
GRIN Therapeutics
GRIN Therapeutics is a clinical-stage biotechnology company focused on developing precision therapeutics for serious pediatric neurodevelopmental disorders. It targets conditions arising from GRIN gene mutations and related neurodevelopmental disorders and is advancing the investigational therapy radiprodil to evaluate its safety and efficacy for GRIN-related disorders, tuberous sclerosis complex, and focal cortical dysplasia.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.